[go: up one dir, main page]

WO2001090115A3 - Haplotypes of the cdk4 gene - Google Patents

Haplotypes of the cdk4 gene Download PDF

Info

Publication number
WO2001090115A3
WO2001090115A3 PCT/US2001/016350 US0116350W WO0190115A3 WO 2001090115 A3 WO2001090115 A3 WO 2001090115A3 US 0116350 W US0116350 W US 0116350W WO 0190115 A3 WO0190115 A3 WO 0190115A3
Authority
WO
WIPO (PCT)
Prior art keywords
haplotypes
cdk4
gene
disclosed
cdk4 gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/016350
Other languages
French (fr)
Other versions
WO2001090115A2 (en
Inventor
Amy E Duda
Amir Kazemi
Beena Koshy
Elizabeth Ann Sausker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Priority to AU2001274874A priority Critical patent/AU2001274874A8/en
Priority to PCT/US2001/016350 priority patent/WO2001090115A2/en
Priority to AU2001274874A priority patent/AU2001274874A1/en
Publication of WO2001090115A2 publication Critical patent/WO2001090115A2/en
Anticipated expiration legal-status Critical
Publication of WO2001090115A3 publication Critical patent/WO2001090115A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Novel genetic variants of the Cyclin-Dependent Kinase 4 (CDK4) gene are described. Various genotypes, haplotypes, and haplotype pairs that exist in the general United States population are disclosed for the CDK4 gene. Compositions and methods for haplotyping and/or genotyping the CDK4 gene in an individual are also disclosed. Polynucleotides defined by the sequence the haplotypes disclosed herein are also described.
PCT/US2001/016350 2000-05-19 2001-05-18 Haplotypes of the cdk4 gene Ceased WO2001090115A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2001274874A AU2001274874A8 (en) 2001-05-18 2001-05-18 Haplotypes of the cdk4 gene
PCT/US2001/016350 WO2001090115A2 (en) 2000-05-19 2001-05-18 Haplotypes of the cdk4 gene
AU2001274874A AU2001274874A1 (en) 2000-05-19 2001-05-18 Haplotypes of the cdk4 gene

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20586700P 2000-05-19 2000-05-19
US60/205,867 2000-05-19
PCT/US2001/016350 WO2001090115A2 (en) 2000-05-19 2001-05-18 Haplotypes of the cdk4 gene

Publications (2)

Publication Number Publication Date
WO2001090115A2 WO2001090115A2 (en) 2001-11-29
WO2001090115A3 true WO2001090115A3 (en) 2003-08-14

Family

ID=27736709

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/016350 Ceased WO2001090115A2 (en) 2000-05-19 2001-05-18 Haplotypes of the cdk4 gene

Country Status (1)

Country Link
WO (1) WO2001090115A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714329A (en) * 1995-11-29 1998-02-03 Sequana Theraputics, Inc. Methods for the diagnosis of a genetic predisposition to cancer associated with variant CDK4 allele

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714329A (en) * 1995-11-29 1998-02-03 Sequana Theraputics, Inc. Methods for the diagnosis of a genetic predisposition to cancer associated with variant CDK4 allele

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 5 June 1996 (1996-06-05), ZUO ET AL., XP002197856, accession no. NCBI Database accession no. (U37022) *

Also Published As

Publication number Publication date
WO2001090115A2 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
WO2002026764A3 (en) Haplotypes of the ccr6 gene
WO2002010454A3 (en) Haplotypes of the alas2 gene
WO2002008425A3 (en) Haplotypes of the adrb3 gene
WO2001090115A3 (en) Haplotypes of the cdk4 gene
WO2002090512A3 (en) Haplotypes of the nnmt gene
WO2002012498A3 (en) Haplotypes of the isl1 gene
WO2002032928A3 (en) Haplotypes of the hrh1 gene
WO2001087909A3 (en) Haplotypes of the aanat gene
WO2001090127A3 (en) Haplotypes of the hoxd3 gene
WO2002032924A3 (en) Haplotypes of the chrm5 gene
WO2002016398A3 (en) Haplotypes of the bmpr2 gene
WO2002036609A3 (en) Haplotypes of the chrm4 gene
WO2002012499A3 (en) Haplotypes of the ntf3 gene
WO2001087906A3 (en) Haplotypes of the stk11 gene
WO2002040502A3 (en) Haplotypes of the lipe gene
WO2001090118A3 (en) Haplotypes of the edn2 gene
WO2002016399A3 (en) Haplotypes of the tacr1 gene
WO2002036610A3 (en) Haplotypes of the adora3 gene
WO2001092278A3 (en) Haplotypes of the rlbp1 gene
WO2002020556A3 (en) Haplotypes of the gpr68 gene
WO2002090378A3 (en) Haplotypes of the ces2 gene
WO2001094365A3 (en) Haplotypes of the phkg2 gene
WO2001085742A3 (en) Haplotypes of the npy1r gene
WO2002042320A3 (en) Haplotypes of the gsr gene
WO2001087908A3 (en) Haplotypes of the ccr3 gene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP